Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Aveanna Healthcare Holdings ( (AVAH) ) is now available.
Aveanna Healthcare reported strong fourth-quarter and full-year 2025 results on March 19, 2026, with Q4 revenue rising 27.4% year over year to $662.5 million and net income jumping to $178.8 million, while adjusted EBITDA grew 54.0% to $85.0 million. For the full year ended January 3, 2026, revenue increased 20.2% to $2.43 billion, net income swung to a $225.0 million profit from a prior-year loss, and adjusted EBITDA surged 74.8% to $320.9 million, driven largely by growth in its private duty services segment.
The company maintained its 2026 guidance for revenue between $2.54 billion and $2.56 billion and adjusted EBITDA of $318 million to $322 million, signaling confidence in its core operations despite not yet factoring in its pending acquisition of Family First Homecare. Aveanna also highlighted solid liquidity and $131.0 million in free cash flow for 2025, although management noted that financing the Family First deal with cash and securitization borrowings is expected to reduce liquidity, underscoring an aggressive yet balance-sheet-conscious expansion strategy in pediatric home care.
The most recent analyst rating on (AVAH) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Aveanna Healthcare Holdings stock, see the AVAH Stock Forecast page.
Spark’s Take on AVAH Stock
According to Spark, TipRanks’ AI Analyst, AVAH is a Neutral.
Overall score reflects weak financial foundation (high leverage and low profitability) and only modest technical momentum, partially offset by strong recent operating performance, raised guidance, and a mid-range valuation.
To see Spark’s full report on AVAH stock, click here.
More about Aveanna Healthcare Holdings
Aveanna Healthcare Holdings Inc., based in Atlanta and listed on Nasdaq, operates a diversified home care platform focused on medically complex, high-cost patient populations. The company delivers care primarily in the home across three operating divisions, including private duty services, home health and hospice, and medical solutions, and has been executing a multi-year strategic transformation with an acquisition-led growth strategy.
Aveanna’s model centers on high-quality, cost-effective in-home clinical care, positioning it within the pediatric and complex-care segment of the broader U.S. home care industry. Recent integrations, such as Thrive Skilled Pediatric Care, and expansion into multi-state pediatric home nursing reflect its emphasis on scaled, specialized services for vulnerable patient groups.
Average Trading Volume: 1,126,587
Technical Sentiment Signal: Buy
Current Market Cap: $1.44B
For detailed information about AVAH stock, go to TipRanks’ Stock Analysis page.